Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CORONA: A Phase 1/2 Study Using DeltaRex-G Gene Therapy for Symptomatic COVID-19

NCT04378244 is registered in ClinicalTrials.gov with Aveni Foundation as lead sponsor.

NCT NCT04378244
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04378244 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CORONA: A Phase 1/2 Study Using DeltaRex-G Gene Therapy for Symptomatic COVID-19
Lead sponsor
Aveni Foundation
Phase
Phase 1/2
Overall status
Withdrawn
Start date
December 12, 2022
Completion date
July 12, 2024
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory distress syndrome, covid-19, cytokine storm